Results 151 to 160 of about 1,119,184 (304)

Quarterly intravenous injection of ibandronate to treat osteoporosis in postmenopausal women

open access: yes, 2007
Philip SambrookUniversity of Sydney, SydneyAbstract: Osteoporosis is a chronic condition that generally requires long-term therapy for fracture risk reduction to become apparent.
Philip Sambrook
core  

How is Nanoarchitectonics Shaping Extracellular Vesicle Research?

open access: yesAdvanced Healthcare Materials, EarlyView.
The convergence of nanoarchitectonics and extracellular vesicle biology is reshaping next‐generation nanomedicine by enabling rationally designed nanostructures for enhanced EVs detection, engineering, and therapy. ABSTRACT Extracellular vesicles (EVs) have gained recognition as crucial mediators of cell‐to‐cell communication, holding immense potential
Madushani Dahanayake   +5 more
wiley   +1 more source

Preincisional administration of intravenous or subcutaneous infiltration of low-dose ketamine suppresses postoperative pain after appendectomy

open access: yes, 2011
Azim Honarmand, Mohammadreza Safavi, Hasan KarakyAnesthesiology and Critical Care Research Center, Isfahan University of Medical Sciences, Isfahan, IranBackground: Ketamine, an N-methyl-D-aspartate receptor antagonist, can suppress hyperalgesia and ...
A, Safavi M, Honarm, Karaky H
core  

Back to the Basics: Response of Alopecia Areata Universalis to Intravenous High-Dose Pulse Corticosteroid Therapy

open access: yesDermatology Practical & Conceptual, 2021
Kerasia-Maria Plachouri   +3 more
doaj   +1 more source

From Cell‐Derived Vesicles to Hybrid Nanovectors: Biological Membranes as Functional Blueprints for Gene Delivery

open access: yesAdvanced Healthcare Materials, EarlyView.
Biologically derived and hybrid nonviral nanovectors are examined as distinct but convergent design approaches. Integrating synthetic components with biologically functionalized membranes allows efficient interactions with complex cellular environments.
Clara Baldari   +10 more
wiley   +1 more source

Engineered Nanoplatforms Targeting Activated Hepatic Stellate Cells for Liver Fibrosis Therapy via TGF‐β Axis Inhibition and Ferroptosis Induction

open access: yesAdvanced Healthcare Materials, EarlyView.
FeS‐VA@lanifibranor (FVL), an activated hepatic stellate cell (aHSC)‐targeted nanoplatform comprising vitamin A‐functionalized two‐dimensional iron sulfide nanosheets and lanifibranor, is engineered for precision therapy of liver fibrosis. FVL suppresses the TGF‐β signaling pathway by inhibiting SMAD2/3 phosphorylation and induces ferroptosis in aHSCs,
Yinuo Yang   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy